BridgeMD
New treatment option for Breast Cancer
Official title Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy
ClinicalTrials.gov ID: NCT03417622
What this study is testing
What is Neoadjuvant therapy?
Neoadjuvant therapy is an investigational medicine, being studied as a potential treatment for breast cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Breast cancer patients often receive systemic drugs as the initial curative treatment of their disease. The initial systemic therapy leads to a variable degree of tumor shrinkage.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Biopsy-proven diagnosis of invasive adenocarcinoma of the breast.
- Tumor stage T 1-4b
- Nodal stage N 0-2
- ASA (American Society of Anesthesiologists) class I-II
You likely can't join if
- Patients opting for mastectomy.
- Patients advised for mastectomy by the treating physician.
- Patients opting for primary surgical treatment.
- Patients advised for primary surgical treatment by the treating physician.
- Metastatic patients.
- Multifocal tumors.
See the full eligibility criteria
- Biopsy-proven diagnosis of invasive adenocarcinoma of the breast.
- Tumor stage T 1-4b
- Nodal stage N 0-2
- ASA (American Society of Anesthesiologists) class I-II
- Patients opting for mastectomy.
- Patients advised for mastectomy by the treating physician.
- Patients opting for primary surgical treatment.
- Patients advised for primary surgical treatment by the treating physician.
- Metastatic patients.
- Multifocal tumors.
- Lobular neoplasia.
- Current pregnancy or pregnancy less than 6 months from the enrollment date.
- Active second cancer.
The study team makes the final eligibility decision.
Where it's taking place
- Al Mansurah, DK, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Mansurah, DK, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.